
Loading, please wait...

Loading, please wait...

Routine HbA1c screening blood donation programs offer a unique opportunity to address the global diabetes epidemic. Since nearly 50% of the 1 in 10 adults with diabetes remain undiagnosed worldwide, community blood centers can serve as pivotal hubs for public health. A recent prospective study highlights the efficacy of this strategy in identifying asymptomatic individuals before complications arise.
The study performed a 1-year analysis and found that 17.7% of donors had elevated HbA1c levels. More importantly, 64.9% of these results represented entirely new diagnoses, with the vast majority (91.6%) being pre-diabetes. This data suggests that blood donation centers reach a healthy-appearing population that might not otherwise seek screening. Furthermore, the findings showed significant demographic variations, indicating that certain age groups and ethnicities are disproportionately underdiagnosed.
Consequently, incorporating routine testing allows for more targeted outreach to vulnerable populations. The research observed that donors with abnormal HbA1c levels actually donated more frequently than those with normal levels. Therefore, providing health feedback during the donation process could significantly improve donor awareness and long-term health outcomes. Additionally, about 17.8% of donors with new diagnoses acknowledged their status during subsequent visits, proving that notification systems work effectively.
While the feasibility of screening is clear, enhanced follow-up strategies are necessary to ensure donors take appropriate clinical action. In India, where diabetes prevalence is rising rapidly, such strategies could alleviate the burden on the primary healthcare system. Moreover, medical professionals should recognize the potential of blood centers as allies in early chronic disease management. However, experts caution that HbA1c results in the Indian population must be interpreted carefully due to the high prevalence of anemia and red blood cell disorders which can affect test accuracy.
It is highly effective for early detection. Research indicates that nearly 65% of elevated results at these centers represent new diagnoses, primarily identifying individuals in the pre-diabetic stage.
Yes, the study found that donors with abnormal levels donated more frequently. Furthermore, early notification empowers them to acknowledge their status and seek further medical consultation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Jamal Y et al. Integrating routine hemoglobin A1c screening in blood donation: A strategy for early diabetes detection and donor health awareness. Transfusion. 2026 Jun 08. doi: 10.1111/trf.70238. PMID: 42253129.
2. Anjana RM, et al. Metabolic non-communicable disease health report of India: The ICMR-INDIAB national cross-sectional study. The Lancet Diabetes & Endocrinology. 2023;11(7):474-489.
3. Misra A, et al. HbA1c test alone may mislead diabetes diagnosis in South Asia: Study. Lancet Regional Health – Southeast Asia. 2026 Feb 10.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A recent study highlights how routine HbA1c screening in blood donation centers can identify undiagnosed diabetes, offering a unique public health opportuni...
4 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today